AP
ALKERMES PLC
ALKS· Health Care· PharmaceuticalsS&P 600
Close · 23/10/2026
43.63
1D
-1.24%52-week range
27 – 55.67
Volume
8,84,600.00
Price history
ALKS
24/09/2026 to 23/10/2026
O 44.15 H 44.15 L 43.15
1W+5.85%
1M+6.96%
3M-17.26%
6M+30.98%
1Y+40.33%
3Y+60.52%
5Y+37.76%
MAX+44.23%
Fundamentals
as of 23/10/2026- Market cap
- $7.32B
- Shares out
- 167.76M
- P/E (trailing)
- 110.70
- P/E (forward)
- 24.13
- EPS (trailing)
- 0.39
- Dividend yield
- 0.00%
- Beta
- 0.27
- Profit margin
- 3.97%
- P/B
- 4.05
- Return on equity
- 3.66%
SEC financial statements
49 quarterly and 17 annual periods through 30/06/2026.
Details
- Ticker
- ALKS
- Index
- SP600
- Sector
- Health Care
- Industry
- Pharmaceuticals
- HQ
- -
Last close 23/10/2026.
Tracked by Congress
1 filer · 0 on watchlist · 2 buys · 0 sells · D: 2
- 29/09/2026Gilbert CisnerosBuyAlkermes plc - Ordinary Shares$1,001–$15,000
- 30/07/2026Gilbert CisnerosBuyAlkermes plc - Ordinary Shares$15,001–$50,000